Acrivon Therapeutics Inc. Common Stock (ACRV) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Acrivon Therapeutics Inc....

    NASDAQ: ACRV · Real-Time Price · USD
    1.91
    0.05 (2.69%)
    At close: Oct 03, 2025, 3:59 PM
    1.91
    -0.04%
    After-hours: Oct 03, 2025, 06:51 PM EDT

    Acrivon Therapeutics Common Stock Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -25.25 -1.8 -8.1 -21.37
    PEG Ratio
    		 0.28 -0.02 -0.1 -0.1
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 11.51 0.90 1.48 -14.58
    P/FCF Ratio
    		 -29.72 -2.47 -7.82 -24.41
    P/OCF Ratio
    		 -30.98 -2.55 -8.38 -24.83
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.02 0.04 0.03 -0.24
    Quick Ratio
    		 10.55 9.75 20.27 34.46
    Current Ratio
    		 10.55 9.75 20.27 34.46
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.46 -0.5 -0.18 0.68
    Return on Assets
    		 -0.41 -0.44 -0.17 -0.15
    Return on Invested Capital
    		 -0.49 -0.53 -0.19 -0.16
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist